MMP-2 and MMP-9 in lymph-node-positive bladder cancer

Area of Science:

• Oncology
• Cancer Biology
• Biochemistry

Background:

• Matrix metalloproteinases (MMP), particularly MMP-2 and MMP-9, are implicated in tumor progression and metastasis across various cancers.
• The specific role of MMP-2 and MMP-9 in urothelial cancer of the bladder (UCB) remains unclear.
• Investigating MMP expression in normal urothelium, primary tumors, and metastases can clarify their relevance in UCB.

Purpose of the Study:

• To analyze the expression of MMP-2 and MMP-9 in urothelial bladder cancer (UCB).
• To correlate MMP expression with tumor characteristics and patient survival.
• To understand the role of MMPs in tumor progression and metastasis in UCB.

Main Methods:

• Evaluated MMP-2 and MMP-9 expression using tissue microarrays (TMA) from 150 surgically treated, lymph-node-positive UCB patients.
• Correlated biomarker expression with primary tumor and lymph node stage, number, total diameter, and extracapsular extension.
• Assessed the relationship between MMP expression and overall survival.

Main Results:

• MMP-9 expression significantly increased from normal urothelium to primary tumors and further to metastases (p<0.005).
• MMP-2 expression did not follow a similar increasing trend (p<0.005).
• No significant difference in MMP-2 or MMP-9 expression was observed between the tumor center and invasion front. No association was found with histopathological tumor characteristics.

Conclusions:

• MMP-2 and MMP-9 expression was not elevated at the invasion front in lymph-node-positive UCB, suggesting infiltration occurs independently of these MMPs.
• Larger studies are required to confirm a potential trend for a favorable outcome in UCB with high MMP-2 expression.